Abivax SA ADR (ABVX)

Currency in USD
69.09
-1.82(-2.57%)
Closed·
After Hours
69.67+0.58(+0.84%)
·
ABVX Scorecard
Full Analysis
RSI suggests the stock is in overbought territory
ABVX is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
67.0972.69
52 wk Range
4.7775.51
Key Statistics
Prev. Close
70.91
Open
70.32
Day's Range
67.09-72.69
52 wk Range
4.77-75.51
Volume
1.64M
Average Volume (3m)
1.2M
1-Year Change
532.11%
Book Value / Share
-0.11
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ABVX Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
95.13
Upside
+37.68%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales decline in the current year

Abivax SA ADR News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell

Abivax SA ADR Company Profile

ABIVAX Société Anonyme, a clinical-stage biotechnology company, focuses on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod that is in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis, as well as in Phase 2b clinical trial to treat patients with Crohn’s disease. The company was incorporated in 2013 and is headquartered in Paris, France.

Compare ABVX to Peers and Sector

Metrics to compare
ABVX
Peers
Sector
Relationship
P/E Ratio
−24.9x−3.0x−0.5x
PEG Ratio
−2.220.050.00
Price/Book
−702.5x1.7x2.6x
Price / LTM Sales
437.4x4.5x3.3x
Upside (Analyst Target)
38.2%143.5%43.5%
Fair Value Upside
Unlock4.7%6.9%Unlock

Analyst Ratings

7 Buy
0 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 95.13
(+37.68% Upside)

Earnings

Latest Release
Jun 02, 2025
EPS / Forecast
-0.9695 / -0.68
Revenue / Forecast
1.16M / --
EPS Revisions
Last 90 days

ABVX Income Statement

People Also Watch

38.47
BMNR
+15.53%
16.26
SRPT
-2.93%
1.900
OPEN
-24.60%
5.50
REPL
-12.97%
13.0600
INKT
-10.12%

FAQ

What Stock Exchange Does Abivax ADR Trade On?

Abivax ADR is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Abivax ADR?

The stock symbol for Abivax ADR is "ABVX."

What Is the Abivax ADR Market Cap?

As of today, Abivax ADR market cap is 5.40B.

What Is Abivax ADR's Earnings Per Share (TTM)?

The Abivax ADR EPS (TTM) is -2.94.

When Is the Next Abivax ADR Earnings Date?

Abivax ADR will release its next earnings report on 07 Sept 2025.

From a Technical Analysis Perspective, Is ABVX a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Abivax ADR Stock Split?

Abivax ADR has split 0 times.

How Many Employees Does Abivax ADR Have?

Abivax ADR has 69 employees.

What is the current trading status of Abivax ADR (ABVX)?

As of 07 Aug 2025, Abivax ADR (ABVX) is trading at a price of 69.09, with a previous close of 70.91. The stock has fluctuated within a day range of 67.09 to 72.69, while its 52-week range spans from 4.77 to 75.51.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.